Works matching IS 09697128 AND DT 2006 AND VI 13 AND IP 2

Results: 9

Epstein–Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination.

Published in:

Gene Therapy, 2006, v. 13, n. 2, p. 150, doi. 10.1038/sj.gt.3302602

By:

Hellebrand, E.;
Mautner, J.;
Reisbach, G.;
Nimmerjahn, F.;
Hallek, M.;
Mocikat, R.;
Hammerschmidt, W.

Publication type:

Article

Tamoxifen-regulated adenoviral E1A chimeras for the control of tumor selective oncolytic adenovirus replication in vitro and in vivo.

Published in:

Gene Therapy, 2006, v. 13, n. 2, p. 173, doi. 10.1038/sj.gt.3302604

By:

Sipo, I.;
Wang, X.;
Picó, A. Hurtado;
Suckau, L.;
Weger, S.;
Poller, W.;
Fechner, H.

Publication type:

Article

Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming.

Published in:

Gene Therapy, 2006, v. 13, n. 2, p. 138, doi. 10.1038/sj.gt.3302609

By:

Errington, F.;
Jones, J.;
Merrick, A.;
Bateman, A.;
Harrington, K.;
Gough, M.;
O'Donnell, D.;
Selby, P.;
Vile, R.;
Melcher, A.

Publication type:

Article

Rapamycin control of transgene expression from a single AAV vector in mouse salivary glands.

Published in:

Gene Therapy, 2006, v. 13, n. 2, p. 187, doi. 10.1038/sj.gt.3302647

By:

Wang, J.;
Voutetakis, A.;
Papa, M.;
Rivera, V. M.;
Clackson, T.;
Lodde, B. M.;
Mineshiba, F.;
Baum, B. J.

Publication type:

Article

Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit.

Published in:

Gene Therapy, 2006, v. 13, n. 2, p. 127, doi. 10.1038/sj.gt.3302631

By:

Lee, K. C.;
Hamstra, D. A.;
Bullarayasamudram, S.;
Bhojani, M. S.;
Moffat, B. A.;
Dornfeld, K. J.;
Ross, B. D.;
Rehemtulla, A.

Publication type:

Article

Bacteria in gene therapy: bactofection versus alternative gene therapy.

Published in:

Gene Therapy, 2006, v. 13, n. 2, p. 101, doi. 10.1038/sj.gt.3302635

By:

Pálffy, R.;
Gardlík, R.;
Hodosy, J.;
Behuliak, M.;
Reško, P.;
Radvánský, J.;
Celec, P.

Publication type:

Article

Enhanced therapeutic efficacy of G207 for the treatment of glioma through Musashi1 promoter retargeting of γ34.5-mediated virulence.

Published in:

Gene Therapy, 2006, v. 13, n. 2, p. 106, doi. 10.1038/sj.gt.3302636

By:

Kanai, R.;
Tomita, H.;
Shinoda, A.;
Takahashi, M.;
Goldman, S.;
Okano, H.;
Kawase, T.;
Yazaki, T.

Publication type:

Article

Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX.

Published in:

Gene Therapy, 2006, v. 13, n. 2, p. 117, doi. 10.1038/sj.gt.3302638

By:

Bigger, B. W.;
Siapati, E. K.;
Mistry, A.;
Waddington, S. N.;
Nivsarkar, M. S.;
Jacobs, L.;
Perrett, R.;
Holder, M. V.;
Ridler, C.;
Kemball-Cook, G.;
Ali, R. R.;
Forbes, S. J.;
Coutelle, C.;
Wright, N.;
Alison, M.;
Thrasher, A. J.;
Bonnet, D.;
Themis, M.

Publication type:

Article

Therapeutic ultrasound-mediated DNA to cell and nucleus: bioeffects revealed by confocal and atomic force microscopy.

Published in:

Gene Therapy, 2006, v. 13, n. 2, p. 163, doi. 10.1038/sj.gt.3302642

By:

Duvshani-Eshet, M.;
Baruch, L.;
Kesselman, E.;
Shimoni, E.;
Machluf, M.

Publication type:

Article